These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16961745)

  • 1. Review article: how to control and improve adherence to therapy in inflammatory bowel disease.
    López-Sanromán A; Bermejo F
    Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():45-9. PubMed ID: 16961745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review article: improving adherence to medication in patients with inflammatory bowel disease.
    Robinson A
    Aliment Pharmacol Ther; 2008 Mar; 27 Suppl 1():9-14. PubMed ID: 18307644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The problems of compliance and adherence, using the example of chronic inflammatory bowel disease].
    Zimmerer T; Siegmund SV; Singer MV
    Dtsch Med Wochenschr; 2009 Jul; 134(27):1417-24. PubMed ID: 19551607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for non-adherence to medication in inflammatory bowel disease patients.
    D'Incà R; Bertomoro P; Mazzocco K; Vettorato MG; Rumiati R; Sturniolo GC
    Aliment Pharmacol Ther; 2008 Jan; 27(2):166-72. PubMed ID: 17949472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suboptimal medication adherence in Parkinson's disease.
    Grosset KA; Bone I; Grosset DG
    Mov Disord; 2005 Nov; 20(11):1502-7. PubMed ID: 16037924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [No response to antihypertensive therapy: consider non-adherence].
    Braam RL; Van Uum SH; Lenders JW; Thien T
    Ned Tijdschr Geneeskd; 2007 Mar; 151(10):569-73. PubMed ID: 17402645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment adherence in inflammatory bowel disease. Strategies for improvement].
    Bermejo San José F; López San Román A; García AA
    Gastroenterol Hepatol; 2009 Oct; 32 Suppl 2():31-6. PubMed ID: 19900626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of medication adherence in inflammatory bowel disease.
    Ediger JP; Walker JR; Graff L; Lix L; Clara I; Rawsthorne P; Rogala L; Miller N; McPhail C; Deering K; Bernstein CN
    Am J Gastroenterol; 2007 Jul; 102(7):1417-26. PubMed ID: 17437505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive perspective on patient adherence to topical glaucoma therapy.
    Tsai JC
    Ophthalmology; 2009 Nov; 116(11 Suppl):S30-6. PubMed ID: 19837258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A triangulation study of the clinician and patient experiences of the use of the immunosuppressant drugs azathioprine and 6-mercaptopurine for the management of inflammatory bowel disease.
    Holbrook K
    J Clin Nurs; 2007 Aug; 16(8):1427-34. PubMed ID: 17655530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence rates with infliximab therapy in Crohn's disease.
    Kane S; Dixon L
    Aliment Pharmacol Ther; 2006 Oct; 24(7):1099-103. PubMed ID: 16984504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cross-national comparison of drug compliance and non-compliance associated factors in the elderly with polypharmacotherapy].
    Topinková E; Fialová D; Carpenter GI; Bernabei R
    Cas Lek Cesk; 2006; 145(9):726-32. PubMed ID: 17091729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adherence to therapy in bronchial asthma].
    Gillissen A; Büsch K; Juergens U
    Dtsch Med Wochenschr; 2007 Jun; 132(23):1281-6. PubMed ID: 17541872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel 5-aminosalicylic acid formulations in ulcerative colitis: old dog, new tricks.
    Wilson J
    Gastroenterol Nurs; 2008; 31(4):286-92. PubMed ID: 18708833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: inflammatory bowel disease--empowering the patient and improving outcome.
    Robinson A
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():84-7. PubMed ID: 15352900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug monitoring in inflammatory bowel disease: helpful or dispensable?
    Bruns T; Stallmach A
    Dig Dis; 2009; 27(3):394-403. PubMed ID: 19786771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic compliance: a prospective analysis of various factors involved in the adherence rate in type 2 diabetes.
    Bezie Y; Molina M; Hernandez N; Batista R; Niang S; Huet D
    Diabetes Metab; 2006 Dec; 32(6):611-6. PubMed ID: 17296515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of chronic inflammatory bowel diseases].
    Lémann M
    Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic alliance, a stake in schizophrenia].
    Charpentier A; Goudemand M; Thomas P
    Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.